Health & Environmental Research Online (HERO)


Print Feedback Export to File
5787784 
Journal Article 
alpha-GalCer C20 : 2 may be a more efficacious candidate drug than alpha-GalCer C26 : 0 (KRN7000) for iNKT cell mediated protection from type 1 diabetes 
Ly, D; Porcelli, S; Rubin, B; Delovitch, T 
2008 
Yes 
Clinical Immunology
ISSN: 1521-6616
EISSN: 1521-7035 
Elsevier 
127 
Elsevier 
S99-S100